# FDA Inspection 1210478 - Gland Pharma Limited, Units I+II Pashamylaram Site - June 27, 2023

Source: https://www.globalkeysolutions.net/records/fda_inspections/gland-pharma-limited-units-iii-pashamylaram-site/cdefda8a-9fac-4c48-90f1-47b5c117ec07
Source feed: FDA_Inspections

> FDA Inspection 1210478 for Gland Pharma Limited, Units I+II Pashamylaram Site on June 27, 2023. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1210478
- Company Name: Gland Pharma Limited, Units I+II Pashamylaram Site
- Inspection Date: 2023-06-27
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1216053 - 2023-08-26](https://www.globalkeysolutions.net/records/fda_inspections/gland-pharma-limited-units-iii-pashamylaram-site/955ba795-ebdd-4ebb-861f-16909163e529)
- [FDA Inspection 1109239 - 2019-11-07](https://www.globalkeysolutions.net/records/fda_inspections/gland-pharma-limited-units-iii-pashamylaram-site/b1e79e8a-4766-4a82-8ce3-2f50924d5757)
- [FDA Inspection 1043371 - 2018-02-23](https://www.globalkeysolutions.net/records/fda_inspections/gland-pharma-limited-units-iii-pashamylaram-site/2a89c877-04b5-44c9-bda9-2d69a6bcbb57)
- [FDA Inspection 944183 - 2015-09-18](https://www.globalkeysolutions.net/records/fda_inspections/gland-pharma-limited-units-iii-pashamylaram-site/d77a2750-82df-4a46-854c-8ebea4093694)

Company: https://www.globalkeysolutions.net/companies/gland-pharma-limited-units-iii-pashamylaram-site/a7dffca3-c5cc-4802-9cab-54995e7133ca

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c